To investigate the ability of some hematologic prognostic scores demonstrating inflammation in predicting sperm presence in testicular sperm extraction (TESE). We retrospectively investigated the medical data of 430 patients with the diagnosis of non-obstruc tive azoospermia (NOA) who had undergone TESE operation consecutively in our institution between the dates of January 2009 and February 2017. In all, 352 patients with the diagnosis of NOA, with bilaterally palpable vas deferens, who had undergone TESE for the first time, were included in the study. Patients with genetic anomalies, genital infection, history of surgery or vasectomy, chronic diseases, history of inflammatory, metabolic, rheumatologic, or malignant diseases, morbid obesity, with the diagnosis of clinical varicocele, or patients who had undergone TESE for the second time were excluded from the study. According to the results of TESE, the patients were divided into two groups as those with sperm retrieval and those without sperm retrieval. These groups were compared in terms of age, infertility duration, body mass index, hormone profile, hematologic parameters, neutrophil-to-lymphocyte ratio (NRL), monocyte-to-eosinophil ratio (MER), and platelet-to-lymphocyte ratio (PLR). The NLR and PLR levels were found to be significantly higher in patients without sperm retrieval at TESE compared to those with sperm retrieval. The logistic regression analysis showed NLR as an independent factor that showed the presence of spermatozoa at TESE (odds ratio: 4.786, %95 confidence interval: 2.667-8.589, p < 0.001). The area under the ROC curve (AUC) for the PLR was determined to be 0.574. As the calculated AUC value of the PLR was below 0.6, there was insufficient evidence determined at TESE to say that it was a reliable marker to indicate the presence of spermatozoa. The area of the MER value under the ROC curve was not statistically significant. It has been demonstrated that systemic inflammation negatively affects the probability of extracting spermatozoa in TESE and NLR is an independent factor indicating the presence of spermatozoa in TESE.
INTRODUCTION
Azoospermia means no spermatozoa in the ejaculate and it is found in 1% of males and 10-15% of those with infertility complaints (Turunc et al., 2010) . Azoospermia is divided into two groups as obstructive and non-obstructive according to its etiology. Non-obstructive azoospermia (NOA) is considered as the absence of spermatozoa in the ejaculate because fully developed spermatozoa in the testes are minimal or cannot be produced (Deruyver et al., 2014) . The up-to-date treatment of NOA is obtaining the spermatozoa via testicular sperm extraction (TESE) and producing pregnancy using this spermatozoa in intra-cytoplasmic sperm injection (ICSI). Today, TESE operations are performed with microscope assistance (micro-TESE).
Although it was initially reported that retrieval rate following a first TESE attempt in a well-defined NOA population was around 50%, recovery rates reported subsequently in literature were inconsistent (Vloeberghs et al., 2015) . Many disorders such as cryptorchidism, varicocele, hypogonadotropic hypogonadism, chromosomal anomalies, and chronic and inflammatory diseases are known to cause NOA.
Systemic inflammation has been shown to cause adverse effects on the sperm quality leading to consequent infertility. The destructive effect of inflammation is known to cause damage to sperm DNA and membrane leading to azoospermia. The inflammatory reactions within the male genital tract are connected with oxidative stress that is harmful, especially in spermatozoa because it damages sperm DNA and causes apoptosis in spermatozoa (Azenabor et al., 2015) .
The neutrophil-to-lymphocyte ratio (NLR), the monocyte-toeosinophil ratio (MER), and the platelet-to-lymphocyte ratio (PLR) have become popular research topics as inflammatory hematologic scores (G€ unes ß et al., 2015) .
There is no precise parameter to predict the sperm presence at TESE before the operation. Although there are publications in the literature on various parameters predicting the sperm presence in TESE (Ramasamy et al., 2009 (Ramasamy et al., , 2014 Turunc et al., 2010; Bernie et al., 2013; Yang et al., 2015) , no publications were found in the literature investigating the relationship between parameters demonstrating systemic inflammation and TESE success.
The aim of this study was to investigate the ability of certain hematologic scores showing systemic inflammation in predicting the presence of spermatozoa in TESE.
MATERIALS AND METHODS
We retrospectively investigated the medical data of 430 patients with the diagnosis of NOA who had undergone the micro-TESE operation consecutively in our institution between the dates of January 2009 and February 2017. This study was conducted in accordance with the declaration of Helsinki and also with approval from the institutional ethics committee. The diagnosis of NOA was confirmed by clinical findings, medical history, physical examination, serum hormone levels, genetic analysis and as suggested by the WHO guideline two semen analysis. Semen analyses were obtained by masturbation after 3-4 days of sexual abstinence.
The levels of serum total testosterone, follicular stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin of the patients, and the genetic analyses (karyotype analysis and Y chromosome microdeletion analysis) results were evaluated. For the hormone profile, blood was drawn from the antecubital vein of the patients after at least 8 h of fasting. Microparticle enzyme immuno-assay method (Roche/Hitachi, Cobas e601, Indianapolis, IN, USA) was used to determine all the hormone levels. For the chromosome analysis, the peripheral venous blood samples of the patients were subjected to 72 h of phytohemagglutinin-induced cell culture. In our clinic, the Y chromosome microdeletion analysis is performed for all patients before the TESE surgery, and TESE is not recommended to patients with AZFa and AZFb deletions. The preoperative complete blood counts (CBC) of all patients were monitored for anesthesia preparation. The hematologic parameters were determined with Coulter LH-780 hematology blood analyzer (Beckman Coulter Inc, Brea, CA, USA). The NLR, MER, and PLR were calculated.
TESE technique
On the day that the TESE operation was planned, additional sperm samples were obtained and it was confirmed that there were no spermatozoa present. Informed consent was obtained from all patients before TESE. All of the patients underwent spinal anesthesia for TESE. A midline scrotal incision was made and the scrotal content was pushed out from the side with the larger testis. The tunica vaginalis was opened and the tunica albuginea that surrounds the testicle was visualized. After this stage, the operation was handled under 209 magnification operating microscope. As described by Schlegel, an avascular area was selected from the antimesenteric area to the tunica albuginea and a 3 cm incision was made with a thin scalpel (Schlegel, 1999) . Small samples were obtained from opaque, large, white tubules in the testicular parenchyma. Each sample was placed in a Petri dish filled with Bouin's solution. All samples were immediately evaluated by an embryologist with a 2009 magnification microscope to investigate the presence of spermatozoa. The operation was terminated when suitable spermatozoa were found for ICSI. If spermatozoa were not detected in the first samples, additional samples were obtained from the same testicle. In cases where the spermatozoa were not found in the samples sent from the larger testis, the samples were also obtained from the contra-lateral testis.
The study included 352 patients with the diagnosis of NOA and bilaterally palpable vas deferens who had undergone micro-TESE operation for the first time. Patients with Klinefelter syndrome and Y chromosome microdeletion, testosterone level lower than 300 ng/dL, genital infection, surgery or vasectomy, diabetes, hypertension, and chronic diseases such as heart and kidney disease, history of inflammatory, metabolic, rheumatologic, and malignant diseases, morbid obesity, clinical varicocele diagnosis, and the patients who had undergone a second micro-TESE operation were excluded from the study.
To investigate the factors affecting sperm retrieval in TESE, the patients were divided into two groups according to the presence of spermatozoa in TESE. Group 1 consisted of patients with sperm retrieval from TESE and Group 2 comprised those without sperm retrieval from TESE. These two groups were compared in terms of age, duration of infertility, BMI, hormone profile, hematologic parameters, NLR, MER, and PLR.
Statistical analysis
The suitability of the normal distribution of the variables was tested with Kolmogorov-Smirnov Test. The categorical variables were described using frequency and percentage, and the numerical variables were described using mean and standard deviation values. The relationship between two categorical variables was investigated using the chi-square test. Two independent means were compared with the Student's T-test or the Mann-Whitney U-test. The ability of the parameters to predict the presence of spermatozoa in the TESE procedure was investigated by the receiver operating curve (ROC) analysis, and the threshold values were calculated using the Youden Index Method. The logistic regression model was used for the multivariate analysis. The study was conducted at a confidence level of 95%. The data analysis was performed using the Statistical Package for the Social Science (SPSS Inc, Chicago, IL, USA) version 22.0 and a p value of <0.05 was considered significant.
RESULTS
A total of 352 patients were included in the study. In all, 208 patients with sperm retrieval in TESE were included in group 1, and 144 patients without sperm retrieval were included in group 2. The overall sperm retrieval rate was 59.09%. The mean age of the patients was 35.0 AE 6.07 years. The mean ages of the first and the second groups were 35.7 AE 6.11 and 33.9 AE 5.88 years, respectively. This difference was statistically significant (p = 0.003).
In group 2, the mean serum FSH and LH levels were statistically significantly higher when compared to group 1 (p < 0.001, p = 0.006, respectively).
NLR was 1.72 AE 0.65 in group 1 and 2.27 AE 1.81 in group 2. This difference was statistically significant (p = <0.001). PLR was 86.7 AE 36.8 in group 1 and 123 AE 219 in group 2. This difference was statistically significant (p = 0.017). There was no statistically significant difference between the two groups in terms of MER (p = 0.443). There were no statistically significant differences between the two groups in terms of other hormones and hematologic parameters.
The clinical characteristics, hormone, and hematologic parameters of the patients in groups 1 and 2 are presented in Table 1 . The ability of the NLR, PLR, and MER parameters to predict the presence of spermatozoa in the TESE procedure was investigated by the ROC analysis and the threshold values were calculated using the Youden Index Method. The results of this analysis and the ROC curve have been displayed in Fig. 1 . The best cutoff value that NLR could predict for sperm retrieval in TESE was 1.89 (sensitivity: 71.6%, specificity: 60.4%, p = 0.001) ( Table 2 ). The area under the ROC curve for the NLR (AUC) was 0.671.
The best cutoff value in which the PLR can predict sperm retrieval in TESE was determined as 79 (Sensitivity: 46.6%, specificity: 66.7%, p = 0.013) ( Table 2 ). The AUC for PLR was 0.574. Since the PLR was below the AUC <0.6, there was insufficient evidence that PRL was a reliable marker of sperm presence in TESE. The area under the curve for the MER value was not statistically significant.
The logistic regression analysis was used to prove that NLR was an independent factor indicating the presence of spermatozoa in TESE. Four different models were used for the analysis. Factors that were related to each other in common terms were analyzed in separate equations. These models have been presented in Table 3 . As a result, it was determined that patients with NLR values of 1.89 and below were 4.6-4.8 times more likely NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.
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to have spermatozoa in the TESE than patients with a value above 1.89. FSH in models 1 and 2, and LH in models 3 and 4 were found as independent predictors of sperm presence in TESE. Only in model 2, age was found as an independent predictor of sperm presence in TESE (Table 3) .
DISCUSSION
In this study, it has been demonstrated that some systemic inflammation-based prognostic scores may be useful in predicting the presence of spermatozoa in the testes before the TESE operation. Currently, there are no clinical parameters for detecting the presence of spermatozoa in NOA patients before the TESE procedure. Nevertheless, various parameters have been developed that are currently being developed to predict the possibility of sperm retrieval in TESE by looking at some clinical and laboratory data before the operation of TESE for the diagnosis of NOA (Deruyver et al., 2014) . There are many articles in the literature about these parameters, such as the testis size, serum hormone profile, testicular histology, and genetic disorders such as Klinefelter syndrome and Y chromosome microdeletion (Bernie et al., 2013) . According to our knowledge, no study has been found in the literature investigating the ability of systemic inflammation-based prognostic scores to predict the presence of spermatozoa in the testes before TESE. Our study is the first study on this subject.
There are various biochemical and hematologic markers in use to measure systemic inflammation. Many of these markers take a long time to yield results and they are costly and limited to clinical use. NLR has been a frequently used marker of systemic inflammation in recent years (Imtiaz et al., 2012) . NLR is a cheap, practical, widely available marker that can easily be calculated by dividing the number of neutrophils by the number of lymphocytes obtained from the pre-surgery routine CBC. There are more than 60 publications in the literature investigating the clinical significance of NLR in various cancers (Guthrie et al., 2013) . In addition, there are many studies in the literature investigating the clinical significance of NLR in hypertension, diabetes, metabolic syndrome, renal diseases, inflammatory diseases, and rheumatologic diseases (G€ ura gac ß & Demirer, 2016). Beside NLR, we also used MER and PLR as indicators of systemic inflammation in our study. The effect of acute or chronic inflammation on the development of male infertility is an important issue in contemporary medicine. Inflammation occurs as a result of a complex reaction of the body to infection, trauma, and chemical substances. Inflammation is known to negatively affect the spermatogenesis steps leading to infertility. Inflammatory conditions are implicated in 15% of male infertility cases (Haidl et al., 2008) . There are various pathologies in the male reproductive tract that cause inflammation. These are mainly ejaculatory duct obstructions, infections, testicular torsion, varicocele, and drug therapy. Patients with these pathologies were excluded from our study and the effect of asymptomatic systemic inflammation on the success of TESE in patients with NOA was investigated. The primary molecules that regulate and direct the inflammatory response are leukocytes. When the testicular tissues of men with idiopathic infertility were examined, leukocyte infiltration was detected in more than 50% of men (Bachir & Jarvi, 2014) . Testicular leukocyte infiltration is also observed in testicular malignant pathologies. It is the blood-testis barrier created by the sertoli cells that protect the testes from the harmful effects of the immune system. This barrier, which is damaged as a result of inflammatory destruction and free oxygen products (ROS) produced by inflammatory cells, has negative effects on spermatogenesis. In patients with inadequate antioxidant mechanisms, ROS can cause damage to sperm membranes and DNA, resulting in azoospermia through apoptosis (Hedger, 1997) . G€ unes ß et al., (2015) investigated the predictive ability of NLR and PLR in diagnosing the testicular torsion, an acute inflammatory condition, and found a statistically significant relationship only between scrotal sensitivity and these rates. Yldrm et al., (2015) investigated the relationship between primary ovarian failure and some systemic inflammation-based prognostic scores in women, and found that the NLR ratio in women with primary ovarian failure was statistically significantly lower than the control group comprising healthy subjects. Thus, they showed the negative effects of the systemic inflammatory response in the etiology of primer ovarian failure. Systemic inflammation, which affects women as well as men, can cause testosterone insufficiency and lead to azoospermia. In our study, NLR and PLR ratios were found to be statistically higher in patients without sperm retrieval in TESE compared to those with sperm retrieval and it was shown that systemic inflammation negatively affected the possibility of sperm retrieval in TESE.
The sperm retrieval rate was identified as 59.09% in our study. In many studies, this rate has been reported at around 50% (Vloeberghs et al., 2015) . Our sperm retrieval rate with TESE may be considered high in comparison to literature. We believe that the rate was high because many patients with factors that could negatively affect sperm retrieval with TESE were excluded from the study.
It was observed that the mean duration of infertility of the patients' included in our study was long. The reason behind long durations may have been the fact that the patient population that applies to our infertility clinic comes from rural areas and has a low socioeconomic status; therefore, patients may have failed to seek the appropriate treatment at relevant health institutions in time. Ramasamy et al. (2014) found that the patients' age had no effect on sperm retrieval in TESE. In our study, patient age was found to be significantly higher in patients with sperm retrieval in TESE than in patients without sperm retrieval. We think that this difference comes out of chance. There are studies in the literature showing that high levels of FSH at pre-TESE do not affect the TESE success and there are other studies showing the opposite as well (Ramasamy et al., 2009) . Yang et al., (2015) reported in their meta-analysis that FSH was a predictor of sperm retrieval in patients with NOA. In our study, FSH and LH levels were statistically higher in the group without sperm retrieval. These values were shown to be independent predictive factors for the possibility of sperm retrieval in TESE. Ramasamy et al., (2013) developed a nomogram using clinical features such as age, testicular volume, FSH, history of cryptorchidism, Klinefelter syndrome or varicocele to predict the TESE outcomes pre-operatively. These nomograms were able to predict sperm retrieval accurately in 59% to 64% of the cases. Similarly, in one other study, it was attempted to predict the sperm retrieval success with TESE using a nomogram designed using six different variables (Cissen et al., 2016) . Although it is unclear whether more data would add to the accuracy of the prediction model, we believe that the accuracy rate of these nomograms will increase with the addition of pre-operative inflammation-based prognostic scores. Clinical studies are required to test our thought.
We are aware of the limitations of our study although it is the only one on the subject in the literature. The first limitation of our study is its retrospective nature. The lack of acute phase reactors such as serum amyloid A protein level, C-reactive protein level, erythrocyte sedimentation rate due to not being routinely investigated, are the other limitations of our study. Another limitation of our study is that the smoking status of patients in our study was not assessed. Not every spermatozoa obtained in TESE can be used in ICSI. It is a limitation that the post-ICSI fertility analysis was not included in our study. Because the data of the biopsy samples obtained in the TESE surgery were not reliable, it was not possible to evaluate the histopathological results of the patients in our study. The fact that the correlation between the patients' testicular histopathologies and their pre-operative inflammation-based prognostic scores could not be assessed is also a limitation of our study.
CONCLUSION
According to our knowledge, this is the first study to investigate the ability of systemic inflammation parameters to predict the presence of spermatozoa in testicles prior to TESE. In our study, the NLR and PLR ratios were found to be statistically higher in patients without sperm retrieval in TESE than in patients with sperm retrieval, and it was shown that systemic inflammation negatively affects the possibility of sperm retrieval in TESE. Larger patient-series, multicenter, prospective studies will more clearly reveal the relationship between systemic inflammation and the TESE success.
